<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-id journal-id-type="hwp">ahaoa</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29223955</article-id><article-id pub-id-type="pmc">5779016</article-id><article-id pub-id-type="doi">10.1161/JAHA.117.006975</article-id><article-id pub-id-type="publisher-id">JAH32730</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Kidney in Cardiovascular Disease</subject></subj-group></subj-group></article-categories><title-group><article-title>High&#x02010;Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery</article-title><alt-title alt-title-type="left-running-head">Smith et&#x000a0;al</alt-title></title-group><contrib-group><contrib id="jah32730-cr-0001" contrib-type="author" corresp="yes"><name><surname>Smith</surname><given-names>Loren E.</given-names></name><degrees>MD, PhD</degrees><address><email>loren.e.smith@vanderbilt.edu</email></address><xref ref-type="aff" rid="jah32730-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32730-cr-0002" contrib-type="author"><name><surname>Smith</surname><given-names>Derek K.</given-names></name><degrees>DDS, PhD</degrees><xref ref-type="aff" rid="jah32730-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jah32730-cr-0003" contrib-type="author"><name><surname>Blume</surname><given-names>Jeffrey D.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jah32730-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jah32730-cr-0004" contrib-type="author"><name><surname>Linton</surname><given-names>MacRae F.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="jah32730-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="jah32730-cr-0005" contrib-type="author"><name><surname>Billings</surname><given-names>Frederic T.</given-names><suffix>IV</suffix></name><degrees>MD, MSc</degrees><xref ref-type="aff" rid="jah32730-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="jah32730-aff-0003">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="jah32730-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Anesthesiology</named-content>
<institution>Vanderbilt University Medical Center</institution>
<named-content content-type="city">Nashville</named-content>
<named-content content-type="country-part">TN</named-content>
</aff><aff id="jah32730-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Biostatistics</named-content>
<institution>Vanderbilt University Medical Center</institution>
<named-content content-type="city">Nashville</named-content>
<named-content content-type="country-part">TN</named-content>
</aff><aff id="jah32730-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>Vanderbilt University Medical Center</institution>
<named-content content-type="city">Nashville</named-content>
<named-content content-type="country-part">TN</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence to</bold> Loren E. Smith, MD, PhD, 1301 Medical Center Dr, Ste 4648 TVC, Office 4644, Nashville, TN 37232. E&#x02010;mail: <email>loren.e.smith@vanderbilt.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><volume>6</volume><issue>12</issue><issue-id pub-id-type="doi">10.1002/jah3.2017.6.issue-12</issue-id><elocation-id>e006975</elocation-id><history><date date-type="received"><day>05</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>05</day><month>10</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution&#x02010;NonCommercial&#x02010;NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JAH3-6-e006975.pdf"/><abstract id="jah32730-abs-0001"><sec id="jah32730-sec-0001"><title>Background</title><p>Acute kidney injury (<styled-content style="fixed-case">AKI</styled-content>) after cardiac surgery is associated with increased short&#x02010; and long&#x02010;term mortality. Inflammation, oxidative stress, and endothelial dysfunction and damage play important roles in the development of <styled-content style="fixed-case">AKI</styled-content>. High&#x02010;density lipoproteins (<styled-content style="fixed-case">HDLs</styled-content>) have anti&#x02010;inflammatory and antioxidant properties and improve endothelial function and repair. Statins enhance <styled-content style="fixed-case">HDL</styled-content>'s anti&#x02010;inflammatory and antioxidant capacities. We hypothesized that a higher preoperative <styled-content style="fixed-case">HDL</styled-content> cholesterol concentration is associated with decreased <styled-content style="fixed-case">AKI</styled-content> after cardiac surgery and that perioperative statin exposure potentiates this association.</p></sec><sec id="jah32730-sec-0002"><title>Methods and Results</title><p>We tested our hypothesis in 391 subjects from a randomized clinical trial of perioperative atorvastatin to reduce <styled-content style="fixed-case">AKI</styled-content> after cardiac surgery. A 2&#x02010;component latent variable mixture model was used to assess the association between preoperative <styled-content style="fixed-case">HDL</styled-content> cholesterol concentration and postoperative change in serum creatinine, adjusted for known <styled-content style="fixed-case">AKI</styled-content> risk factors and suspected confounders. Interaction terms were used to examine the effects of preoperative statin use, preoperative statin dose, and perioperative atorvastatin treatment on the association between preoperative <styled-content style="fixed-case">HDL</styled-content> and <styled-content style="fixed-case">AKI</styled-content>. A higher preoperative <styled-content style="fixed-case">HDL</styled-content> cholesterol concentration was independently associated with a decreased postoperative serum creatinine change (<italic>P</italic>=0.02). The association between a high <styled-content style="fixed-case">HDL</styled-content> concentration and an attenuated increase in serum creatinine was strongest in long&#x02010;term statin&#x02010;using patients (<italic>P</italic>=0.008) and was further enhanced with perioperative atorvastatin treatment (<italic>P</italic>=0.004) and increasing long&#x02010;term statin dose (<italic>P</italic>=0.003).</p></sec><sec id="jah32730-sec-0003"><title>Conclusions</title><p>A higher preoperative <styled-content style="fixed-case">HDL</styled-content> cholesterol concentration was associated with decreased <styled-content style="fixed-case">AKI</styled-content> after cardiac surgery. Preoperative and perioperative statin treatment enhanced this association, demonstrating that pharmacological potentiation is possible during the perioperative period.</p></sec><sec id="jah32730-sec-0004"><title>Clinical Trial Registration</title><p>
<styled-content style="fixed-case">URL</styled-content>: <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</ext-link>. Unique Identifier: <styled-content style="fixed-case">NCT</styled-content>00791648.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah32730-kwd-0001">acute kidney injury</kwd><kwd id="jah32730-kwd-0002">cardiac surgery</kwd><kwd id="jah32730-kwd-0003">high&#x02010;density lipoproteins</kwd><kwd id="jah32730-kwd-0004">renal insufficiency</kwd><kwd id="jah32730-kwd-0005">statin</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Clinical Studies</kwd><kwd>Lipids and Cholesterol</kwd><kwd>Nephrology and Kidney</kwd><kwd>Cardiovascular Surgery</kwd><kwd>Complications</kwd></kwd-group><funding-group><award-group><funding-source>National Institutes of Health</funding-source><award-id>T32 GM108554</award-id><award-id>P01 HL116263</award-id><award-id>K23 GM102676</award-id><award-id>R01 GM112871</award-id><award-id>UL1 TR000445</award-id></award-group><award-group><funding-source>Vanderbilt University Medical Center Department of Anesthesiology</funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="9"/><word-count count="5708"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jah32730</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.8 mode:remove_FC converted:27.12.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jah32730-cit-1001">(<source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:<elocation-id>e006975</elocation-id> DOI: <ext-link ext-link-type="doi" xlink:href="10.1161/JAHA.117.006975">10.1161/JAHA.117.006975</ext-link>.)<pub-id pub-id-type="pmid">29223955</pub-id></mixed-citation>
</p></notes></front><body><p>
<boxed-text position="anchor" content-type="box" id="jah32730-blkfxd-0001" orientation="portrait"><sec id="jah32730-sec-0006"><title>Clinical Perspective</title><sec id="jah32730-sec-0007"><title>What Is New?</title><p>
<list list-type="bullet" id="jah32730-list-0001"><list-item><p>In a 391&#x02010;patient study, a higher preoperative high&#x02010;density lipoprotein (HDL) cholesterol concentration was independently associated with a decreased risk of acute kidney injury (AKI) after cardiac surgery, and preoperative and perioperative statin exposure strengthened this association between increased HDL and decreased AKI.</p></list-item><list-item><p>This is the first study to identify HDL as a novel and potentially modifiable risk factor for postoperative AKI.</p></list-item></list>
</p></sec><sec id="jah32730-sec-0008"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah32730-list-0002"><list-item><p>These studies provide evidence that an HDL effect on postoperative AKI can be rapidly pharmacologically modified during the perioperative period.</p></list-item><list-item><p>Therapies that increase preoperative HDL cholesterol concentration or function might reduce the incidence and severity of AKI after cardiac surgery.</p></list-item></list>
</p></sec></sec></boxed-text>
</p><sec id="jah32730-sec-0009"><p>Acute kidney injury (AKI) is estimated to occur in up to 30% of patients after cardiac surgery and is associated with an increased risk of postoperative myocardial injury and both short&#x02010; and long&#x02010;term mortality.<xref rid="jah32730-bib-0001" ref-type="ref">1</xref>, <xref rid="jah32730-bib-0002" ref-type="ref">2</xref>, <xref rid="jah32730-bib-0003" ref-type="ref">3</xref>, <xref rid="jah32730-bib-0004" ref-type="ref">4</xref> AKI after cardiac surgery is the second most common cause of AKI in patients in the intensive care unit.<xref rid="jah32730-bib-0005" ref-type="ref">5</xref> Although overall morbidity and mortality after cardiac surgery have decreased during the past decade, the incidence of AKI after cardiac surgery has not changed.<xref rid="jah32730-bib-0006" ref-type="ref">6</xref> Effective preventative methods and treatments for postoperative AKI are needed.</p><p>Inflammation, oxidative stress, and endothelial dysfunction and damage play important roles in the development of postoperative AKI and could be exploited to reduce AKI.<xref rid="jah32730-bib-0007" ref-type="ref">7</xref>, <xref rid="jah32730-bib-0008" ref-type="ref">8</xref>, <xref rid="jah32730-bib-0009" ref-type="ref">9</xref>, <xref rid="jah32730-bib-0010" ref-type="ref">10</xref>, <xref rid="jah32730-bib-0011" ref-type="ref">11</xref>, <xref rid="jah32730-bib-0012" ref-type="ref">12</xref> High&#x02010;density lipoproteins (HDLs) have systemic anti&#x02010;inflammatory and antioxidant properties and limit endothelial dysfunction and damage by attenuating endothelial cell activation and adhesion molecule expression, by activating endothelial nitric oxide synthase, and by promoting endothelial repair.<xref rid="jah32730-bib-0010" ref-type="ref">10</xref>, <xref rid="jah32730-bib-0013" ref-type="ref">13</xref>, <xref rid="jah32730-bib-0014" ref-type="ref">14</xref>, <xref rid="jah32730-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32730-bib-0016" ref-type="ref">16</xref>, <xref rid="jah32730-bib-0017" ref-type="ref">17</xref>, <xref rid="jah32730-bib-0018" ref-type="ref">18</xref>, <xref rid="jah32730-bib-0019" ref-type="ref">19</xref>, <xref rid="jah32730-bib-0020" ref-type="ref">20</xref> In critically ill patients with pneumonia or sepsis, low HDL cholesterol concentrations are associated with multiorgan dysfunction and short&#x02010; and long&#x02010;term death.<xref rid="jah32730-bib-0021" ref-type="ref">21</xref>, <xref rid="jah32730-bib-0022" ref-type="ref">22</xref> In a similar manner among cardiac surgery patients, a low HDL cholesterol concentration could increase the risk of organ dysfunction, including postoperative AKI, and conversely, a high concentration of HDL cholesterol could decrease the risk of postoperative AKI. Furthermore, in patients undergoing cardiac surgery, who are frequently prescribed statins, any effect of HDL on postoperative AKI risk might be altered by statin exposure, because statin treatment both modestly increases HDL cholesterol concentration and increases the anti&#x02010;inflammatory and antioxidant capacities of HDL.<xref rid="jah32730-bib-0023" ref-type="ref">23</xref>, <xref rid="jah32730-bib-0024" ref-type="ref">24</xref>, <xref rid="jah32730-bib-0025" ref-type="ref">25</xref>, <xref rid="jah32730-bib-0026" ref-type="ref">26</xref>
</p><p>We conducted this study to test the hypothesis that a high preoperative HDL cholesterol concentration is associated with a reduced risk of AKI after cardiac surgery and that perioperative statin exposure potentiates this association.</p></sec><sec id="jah32730-sec-0010"><title>Methods</title><sec id="jah32730-sec-0011"><title>Patients</title><p>We tested our hypothesis in the Statin AKI Cardiac Surgery Randomized Clinical Trial cohort, a recently completed double&#x02010;blind, placebo&#x02010;controlled, randomized clinical trial of high&#x02010;dose perioperative atorvastatin to reduce AKI after cardiac surgery.<xref rid="jah32730-bib-0027" ref-type="ref">27</xref> The trial included patients undergoing elective coronary artery bypass grafting, valve surgery, or ascending aortic surgery requiring thoracotomy or sternotomy at Vanderbilt University Medical Center (VUMC; Nashville, TN). Patients receiving preoperative renal replacement therapy and patients with liver dysfunction, acute coronary syndrome, pregnancy, current CYP3A4 inhibitor use, a history of kidney transplant, or statin intolerance were excluded. The VUMC Institutional Review Board approved the study, all participants provided written informed consent, and the trial was conducted according to the Declaration of Helsinki.</p><p>Preoperative statin&#x02010;using patients were randomly assigned to receive 80&#x000a0;mg atorvastatin on the morning of surgery and 40&#x000a0;mg on the morning of postoperative day 1 or a matching placebo regimen; they resumed their prestudy statin (type and dose) on postoperative day 2. Preoperative statin&#x02010;na&#x000ef;ve patients were randomly assigned to receive 80&#x000a0;mg of atorvastatin the morning before surgery, 40&#x000a0;mg the morning of surgery, and 40&#x000a0;mg daily thereafter throughout hospitalization or a matching placebo regimen. The VUMC investigational drug service compounded all atorvastatin and placebo study drug capsules, identical in size, weight, color, and taste, and dispensed study drug in response to physician order based on stratified randomization lists created by the study's biostatistician. Randomization was stratified by prestudy statin use and chronic kidney disease in permuted blocks to ensure that prestudy statin users and those with chronic kidney disease were equally assigned atorvastatin or placebo treatment. The VUMC investigational drug service documented study drug assignments in a private log. Study drug given on the day of surgery was given at least 3&#x000a0;hours before surgery.</p></sec><sec id="jah32730-sec-0012"><title>Sample Collection</title><p>Blood was collected at induction of anesthesia into a BD lithium heparin vacutainer for plasma lipoprotein and lipid measurements. The sample was delivered to the VUMC Clinical Laboratory Improvement Amendment&#x02013;certified clinical laboratory. HDL cholesterol and triglyceride measurements were made using a selective enzymatic hydrolysis method, and low&#x02010;density lipoprotein cholesterol measurements were made using a measured light selective detergent method on an Abbott ACHITECT platform, Clinical Chemistry model.</p></sec><sec id="jah32730-sec-0013"><title>Acute Kidney Injury</title><p>AKI was defined as the maximum change in serum creatinine concentration from baseline to 48&#x000a0;hours after surgery (&#x00394;SCr). We further staged AKI as mild, moderate, or severe using serum creatinine&#x02013;based AKI Network (AKIN) criteria.<xref rid="jah32730-bib-0006" ref-type="ref">6</xref> AKIN criteria define stage 1 (mild) AKI as a 0.3&#x000a0;mg/dL or 50% increase in serum creatinine concentration from baseline, stage 2 (moderate) as a 100% increase, and stage 3 (severe) as a 200% increase or the initiation of dialysis. Baseline serum creatinine concentration measurements were obtained for inpatient study participants on the morning of surgery and for outpatient study participants during the preoperative clinic assessment. Postoperative serum creatinine concentration measurements were obtained at 2:00&#x000a0;<sc>am</sc> daily until hospital discharge. All serum creatinine concentrations were measured in the clinical laboratory.</p><p>All patient demographic and clinical data were prospectively collected by trained research staff. All serum creatinine data were complete, and &#x0003e;99% of all covariate data were complete.</p></sec><sec id="jah32730-sec-0014"><title>Statistical Analysis</title><p>Demographic, laboratory, and clinical data were summarized as the 50th (10th&#x02013;90th) percentile for continuous variables and as number (percentage) for binary variables. Pearson correlation coefficients were calculated for preoperative HDL concentrations and all available AKI risk factors to evaluate confounding potential. The Mann&#x02010;Whitney <italic>U</italic> test was used to compare distributions of preoperative HDL, low&#x02010;density lipoprotein, and triglyceride concentrations between patients who did and did not have long&#x02010;term statin exposure, between patients who were assigned atorvastatin versus placebo, and between patients who experienced moderate or severe AKI versus patients who experienced mild or no AKI. The Mann&#x02010;Whitney <italic>U</italic> test was also used to compare the distributions of &#x00394;SCr between patients who did and did not have long&#x02010;term statin exposure.</p><p>A 2&#x02010;component latent variable mixture model was used to evaluate the adjusted association between preoperative HDL concentration and &#x00394;SCr (primary analysis).<xref rid="jah32730-bib-0028" ref-type="ref">28</xref> All model covariates were selected <italic>a priori</italic> and included potential confounders of the HDL&#x02010;AKI association and risk factors for AKI that were unlikely to be on the causal pathway between HDL and AKI. These covariates were age, sex, body mass index, history of diabetes mellitus, baseline estimated glomerular filtration rate,<xref rid="jah32730-bib-0029" ref-type="ref">29</xref> valve surgery, intraoperative red blood cell transfusion volume, and intraoperative hydroxyethyl starch transfusion volume. Body mass index and age were modeled flexibly using cubic splines, because they were suspected to be influential potential confounders based on previous work in cardiac surgery patient populations.<xref rid="jah32730-bib-0011" ref-type="ref">11</xref> All risk factor interpretation was based on the nontrivial model component.</p><p>To determine if statin exposure modified the association between preoperative HDL cholesterol concentration and AKI, interaction terms for HDL concentration and long&#x02010;term statin use, HDL concentration and long&#x02010;term statin dose among long&#x02010;term statin users, and HDL concentration and perioperative atorvastatin treatment were individually incorporated into the model and assessed. To compare patients exposed long&#x02010;term to different statins we calculated daily atorvastatin equivalents based on relative low&#x02010;density lipoprotein&#x02013;lowering efficacy.<xref rid="jah32730-bib-0030" ref-type="ref">30</xref> For example, 5&#x000a0;mg rosuvastatin, 40&#x000a0;mg simvastatin, and 80&#x000a0;mg pravastatin were all considered equivalent to 20&#x000a0;mg atorvastatin. The effects of sex and race on the association between HDL cholesterol concentration and &#x00394;SCr were also explored using linear regression.</p><p>For all analyses, a type I error rate of 5% was used to determine statistical significance. All analyses were performed using R (version 3.2.0; R Foundation; <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">http://www.r-project.org</ext-link>). Flexmix and pROC packages were used.</p></sec></sec><sec id="jah32730-sec-0015"><title>Results</title><sec id="jah32730-sec-0016"><title>Study Participants</title><p>Six hundred fifty&#x02010;three patients were enrolled in the trial. Thirty&#x02010;eight of these patients subsequently failed to meet the inclusion criteria or voluntarily withdrew from the study before trial initiation and randomization. We did not collect samples on 224 patients to focus trial research personnel efforts on subject recruitment. Thus, 391 patients constitute the study cohort. There were no differences in patient characteristics, treatment effects, or outcomes between the subjects sampled and those not sampled. The median (10th&#x02013;90th percentile) age of patients in this cohort was 67&#x000a0;(50&#x02013;81) years, and one third of patients were women. Of the patients, 244 (62.6%) were using statins before study enrollment, whereas 147 (37.6%) were statin&#x02010;na&#x000ef;ve. One hundred and twenty&#x02010;three of the statin&#x02010;using patients (50.4%) and 77 (52.4%) of the statin&#x02010;na&#x000ef;ve patients were assigned perioperative atorvastatin treatment, whereas the remaining patients were assigned placebo. Three quarters of the patients were exposed to cardiopulmonary bypass, two thirds had valve repair or replacement, and half underwent coronary artery bypass surgery (<xref rid="jah32730-tbl-0001" ref-type="table-wrap">Table</xref>).</p><table-wrap id="jah32730-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Study Cohort Characteristics</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th><th align="left" valign="top" rowspan="1" colspan="1">Patients (n=391)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="left" rowspan="1" colspan="1">67 (50 to 81)</td></tr><tr><td align="left" rowspan="1" colspan="1">Female sex</td><td align="left" rowspan="1" colspan="1">126 (32.2)</td></tr><tr><td align="left" rowspan="1" colspan="1">White race</td><td align="left" rowspan="1" colspan="1">371 (94.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">28 (23 to 37)</td></tr><tr><td align="left" colspan="2" rowspan="1">Medical history</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">343 (87.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Angina</td><td align="left" rowspan="1" colspan="1">159 (40.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Congestive heart failure</td><td align="left" rowspan="1" colspan="1">155 (39.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peripheral vascular disease</td><td align="left" rowspan="1" colspan="1">108 (27.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">123 (31.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Current smoker</td><td align="left" rowspan="1" colspan="1">67 (17.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Long&#x02010;term statin use</td><td align="left" rowspan="1" colspan="1">244 (62.4)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Long&#x02010;term ACE inhibitor use</td><td align="left" rowspan="1" colspan="1">126 (32.2)</td></tr><tr><td align="left" colspan="2" rowspan="1">Baseline laboratory data</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Total cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">130 (94 to 174)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">HDL cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">36 (25 to 54)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Low&#x02010;density lipoprotein cholesterol, mg/dL</td><td align="left" rowspan="1" colspan="1">71 (43 to 109)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Triglycerides, mg/dL</td><td align="left" rowspan="1" colspan="1">97 (50 to 190)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">eGFR, mL/min per 1.73&#x000a0;m<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">72.8 (40.0 to 97.4)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Creatinine, mg/dL</td><td align="left" rowspan="1" colspan="1">1.01 (0.73 to 1.59)</td></tr><tr><td align="left" colspan="2" rowspan="1">Procedure characteristics</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valve surgery</td><td align="left" rowspan="1" colspan="1">251 (64.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">CABG surgery</td><td align="left" rowspan="1" colspan="1">195 (49.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cardiopulmonary bypass use</td><td align="left" rowspan="1" colspan="1">273 (69.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cardiopulmonary bypass duration, min</td><td align="left" rowspan="1" colspan="1">108 (0 to 211)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aortic cross&#x02010;clamp use</td><td align="left" rowspan="1" colspan="1">186 (47.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Intraoperative hydroxyethyl starch volume, mL</td><td align="left" rowspan="1" colspan="1">0 (0 to 0)<xref ref-type="fn" rid="jah32730-note-0002">a</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Intraoperative red blood cell transfusion, U</td><td align="left" rowspan="1" colspan="1">0 (0 to 4)</td></tr><tr><td align="left" colspan="2" rowspan="1">Outcomes</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" rowspan="1">AKI at 48&#x000a0;h</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Any stage</td><td align="left" rowspan="1" colspan="1">89 (22.8)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Stage 1</td><td align="left" rowspan="1" colspan="1">76 (19.4)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Stage 2</td><td align="left" rowspan="1" colspan="1">4 (1.0)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Stage 3</td><td align="left" rowspan="1" colspan="1">9 (2.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Maximum creatinine change, mg/dL</td><td align="left" rowspan="1" colspan="1">0.09 (&#x02212;0.11 to 0.59)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Dialysis, postoperative</td><td align="left" rowspan="1" colspan="1">6 (1.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">CKMB, postoperative day 1, mg/dL</td><td align="left" rowspan="1" colspan="1">24 (6 to 87)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TIA or stroke</td><td align="left" rowspan="1" colspan="1">14 (3.6)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Length of stay, d</td><td align="left" rowspan="1" colspan="1">7 (5 to 12)</td></tr></tbody></table><table-wrap-foot><fn id="jah32730-note-0001"><p>Continuous variables are reported as 50th (10th to 90th) percentile, and binary variables are reported as number (percentage). ACE indicates angiotensin&#x02010;converting enzyme; AKI, acute kidney injury; CABG, coronary artery bypass graft; CKMB, creatine kinase myocardial band; eGFR, estimated glomerular filtration rate; HDL, high&#x02010;density lipoprotein; and TIA, transient ischemic attack.</p></fn><fn id="jah32730-note-0002"><label>a</label><p>Only 55 of 391 patients received intravenous hydroxyethyl starch during surgery, accounting for the low 10th, 50th, and 90th percentile values.</p></fn></table-wrap-foot></table-wrap></sec><sec id="jah32730-sec-0017"><title>High&#x02010;Density Lipoprotein</title><p>The median (10th&#x02013;90th percentile) preoperative HDL cholesterol concentration was 36&#x000a0;(25&#x02013;54) mg/dL in the total cohort. Among statin&#x02010;using patients, it was 36&#x000a0;(25&#x02013;51) mg/dL; and among statin&#x02010;na&#x000ef;ve patients, it was 37&#x000a0;(25&#x02013;56) mg/dL. There was no difference in preoperative HDL cholesterol concentration between statin&#x02010;using and statin&#x02010;na&#x000ef;ve patients (<italic>P</italic>=0.13). Trial&#x02010;dictated atorvastatin treatment did not affect preoperative HDL cholesterol concentrations. Among patients assigned atorvastatin, the median (10th&#x02013;90th percentile) HDL cholesterol concentration was 35 (23&#x02013;52) mg/dL; and among patients assigned placebo, the median (10th&#x02013;90th percentile) HDL cholesterol concentration was 37&#x000a0;(26&#x02013;55) mg/dL (<italic>P</italic>=0.09). Preoperative HDL cholesterol concentration was not associated with baseline estimated glomerular filtration rate (Pearson correlation coefficient=&#x02212;0.04; 95% confidence interval, &#x02212;0.06 to 0.14).</p></sec><sec id="jah32730-sec-0018"><title>Acute Kidney Injury</title><p>The median (10th&#x02013;90th percentile) &#x00394;SCr was 0.09 (&#x02212;0.11 to 0.59) mg/dL. Eighty&#x02010;nine patients (22.8%) developed AKIN&#x02010;based AKI after surgery. Trial&#x02010;dictated atorvastatin treatment did not affect &#x00394;SCr or the incidence of AKIN&#x02010;defined AKI.<xref rid="jah32730-bib-0027" ref-type="ref">27</xref> There was also no difference in median postoperative &#x00394;SCr between statin&#x02010;na&#x000ef;ve patients and long&#x02010;term statin&#x02010;using patients (<italic>P</italic>=0.37).</p><p>In the primary adjusted analysis, higher preoperative HDL concentration was independently associated with lower &#x00394;SCr (<italic>P</italic>=0.02; Figure&#x000a0;<xref rid="jah32730-fig-0001" ref-type="fig">1</xref>). Specifically, each 10&#x02010;mg/dL increase in preoperative HDL cholesterol concentration was independently associated with a 0.05&#x02010;mg/dL decrease in &#x00394;SCr. There were no sex&#x02010; or race&#x02010;based differences in the association between preoperative HDL cholesterol concentration and postoperative &#x00394;SCr (<italic>P</italic>=0.59 and <italic>P</italic>=0.22, respectively). In addition, the median (10th&#x02013;90th percentile) preoperative HDL cholesterol concentration was 21% lower among patients who experienced stage 2 or stage 3 AKI (28.5 [14.0&#x02013;51.5] mg/dL) compared with patients who experienced stage 1 or no AKI (36.0 [25.0&#x02013;54.0] mg/dL; <italic>P</italic>=0.04).</p><fig fig-type="Figure" xml:lang="en" id="jah32730-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Partial effect plot showing the association between preoperative high&#x02010;density lipoprotein (<styled-content style="fixed-case">HDL</styled-content>) cholesterol concentration and 48&#x02010;hour postoperative maximum serum creatinine change from baseline (&#x00394;SCr), adjusted for model covariates. The x&#x02010;axis rug plot displays the distribution of subjects. Gray shading designates the 95% confidence interval.</p></caption><graphic id="nlm-graphic-1" xlink:href="JAH3-6-e006975-g001"/></fig><p>The median preoperative low&#x02010;density lipoprotein cholesterol and triglyceride concentrations were the same in patients who experienced stage 2 or 3 AKI compared with patients who experienced stage 1 or no AKI (<italic>P</italic>=0.17 and <italic>P</italic>=0.07, respectively).</p></sec><sec id="jah32730-sec-0019"><title>Statin Exposure Interaction</title><p>The magnitude of the association between elevated preoperative HDL concentration and decreased postoperative &#x00394;SCr was stronger among patients receiving long&#x02010;term statin therapy (<italic>P</italic>=0.008 for long&#x02010;term statin use interaction term; Figure&#x000a0;<xref rid="jah32730-fig-0002" ref-type="fig">2</xref>). For example, a 10&#x02010;mg/dL increase in preoperative HDL cholesterol concentration was associated with a 0.11&#x02010;mg/dL decrease in &#x00394;SCr in statin&#x02010;using patients but only a 0.01&#x02010;mg/dL decrease in statin&#x02010;na&#x000ef;ve patients.</p><fig fig-type="Figure" xml:lang="en" id="jah32730-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Partial effect plot of preoperative high&#x02010;density lipoprotein (<styled-content style="fixed-case">HDL</styled-content>) cholesterol concentration vs 48&#x02010;hour postoperative maximum serum creatinine change from baseline (&#x00394;SCr), adjusted for model covariates, demonstrating long&#x02010;term statin therapy effect modification. The x&#x02010;axis rug plot displays the distribution of subjects. Gray shading designates the 95% confidence interval.</p></caption><graphic id="nlm-graphic-3" xlink:href="JAH3-6-e006975-g002"/></fig><p>The magnitude of the association between elevated HDL concentration and decreased postoperative &#x00394;SCr was further strengthened by perioperative atorvastatin exposure, particularly among long&#x02010;term statin&#x02010;using patients (<italic>P</italic>=0.004 for perioperative atorvastatin treatment and long&#x02010;term statin exposure interaction; Figure&#x000a0;<xref rid="jah32730-fig-0003" ref-type="fig">3</xref>), in which each 10&#x02010;mg/dL increase in HDL cholesterol concentration was associated with a 0.17&#x02010;mg/dL decrease in &#x00394;SCr. Increasing dosage of long&#x02010;term statin exposure further amplified the association between high preoperative HDL concentration and decreased postoperative &#x00394;SCr (<italic>P</italic>=0.003 for long&#x02010;term statin dose interaction term; Figure&#x000a0;<xref rid="jah32730-fig-0004" ref-type="fig">4</xref>). For example, among patients taking an 80&#x02010;mg atorvastatin equivalent dose long&#x02010;term. a 10&#x02010;mg/dL increase in HDL cholesterol concentration was associated with a 0.36&#x02010;mg/dL decrease in &#x00394;SCr, compared with a 0.08&#x02010;mg/dL decrease in &#x00394;SCr in patients taking a 10&#x02010;mg atorvastatin equivalent dose long&#x02010;term.</p><fig fig-type="Figure" xml:lang="en" id="jah32730-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Partial effect plot of preoperative high&#x02010;density lipoprotein (<styled-content style="fixed-case">HDL</styled-content>) cholesterol concentration vs 48&#x02010;hour postoperative maximum serum creatinine change from baseline (&#x00394;SCr), adjusted for model covariates, demonstrating long&#x02010;term statin therapy and perioperative atorvastatin treatment effect modification. The x&#x02010;axis rug plot displays the distribution of subjects. Gray shading designates the 95% confidence interval.</p></caption><graphic id="nlm-graphic-5" xlink:href="JAH3-6-e006975-g003"/></fig><fig fig-type="Figure" xml:lang="en" id="jah32730-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Partial effect plot of preoperative high&#x02010;density lipoprotein (<styled-content style="fixed-case">HDL</styled-content>) cholesterol concentration vs 48&#x02010;hour postoperative maximum serum creatinine change from baseline (&#x00394;SCr), adjusted for model covariates, demonstrating long&#x02010;term statin dose and perioperative atorvastatin treatment effect modification. The x&#x02010;axis rug plot displays the distribution of subjects. Gray shading designates the 95% confidence interval.</p></caption><graphic id="nlm-graphic-7" xlink:href="JAH3-6-e006975-g004"/></fig></sec></sec><sec id="jah32730-sec-0020"><title>Discussion</title><p>In this study, a higher preoperative HDL cholesterol concentration was independently associated with decreased AKI after cardiac surgery. This association was potentiated by preoperative statin exposure and by perioperative atorvastatin treatment.</p><p>Previous epidemiologic studies have been restricted to measuring the association between HDL cholesterol concentration and long&#x02010;term renal function. In these studies, a low HDL concentration was associated with a reduced glomerular filtration rate.<xref rid="jah32730-bib-0031" ref-type="ref">31</xref> Because our assessment of HDL concentration on postoperative AKI was adjusted for baseline estimated glomerular filtration rate, and also because HDL concentration was not associated with baseline estimated glomerular filtration rate, the association between elevated preoperative HDL concentration and decreased AKI identified in this study is unlikely to be an effect of HDL concentration on long&#x02010;term renal function.</p><p>This work is the first to suggest a role for HDL in the prevention of postoperative AKI. Currently, the interaction between HDL and the nephron, both in the short&#x02010; and long&#x02010;term, is poorly understood. Systemically, high HDL concentrations have been associated with decreased inflammatory cytokine levels and decreased systemic oxidative stress via associated antioxidant enzymes and by acting as acceptors of prooxidant lipids.<xref rid="jah32730-bib-0013" ref-type="ref">13</xref>, <xref rid="jah32730-bib-0017" ref-type="ref">17</xref>, <xref rid="jah32730-bib-0018" ref-type="ref">18</xref>, <xref rid="jah32730-bib-0019" ref-type="ref">19</xref>, <xref rid="jah32730-bib-0020" ref-type="ref">20</xref> In addition, high HDL concentrations are associated with decreased endothelial adhesion molecule expression, increased endothelial nitric oxide production, and decreased endothelial damage.<xref rid="jah32730-bib-0014" ref-type="ref">14</xref>, <xref rid="jah32730-bib-0016" ref-type="ref">16</xref>, <xref rid="jah32730-bib-0017" ref-type="ref">17</xref> Decreased HDL anti&#x02010;inflammatory, antioxidant, and endothelial protective capacities are associated with an increased risk of chronic kidney disease.<xref rid="jah32730-bib-0032" ref-type="ref">32</xref>, <xref rid="jah32730-bib-0033" ref-type="ref">33</xref>, <xref rid="jah32730-bib-0034" ref-type="ref">34</xref>, <xref rid="jah32730-bib-0035" ref-type="ref">35</xref> Each of these processes (systemic inflammation, oxidative stress, and endothelial dysfunction and damage) plays a key role in the pathogenesis of AKI.<xref rid="jah32730-bib-0009" ref-type="ref">9</xref>, <xref rid="jah32730-bib-0011" ref-type="ref">11</xref>, <xref rid="jah32730-bib-0035" ref-type="ref">35</xref>, <xref rid="jah32730-bib-0036" ref-type="ref">36</xref>, <xref rid="jah32730-bib-0037" ref-type="ref">37</xref> Therefore, in an analogous manner to their role in chronic kidney dysfunction, these HDL functional capacities could contribute to postoperative renal function and AKI.</p><p>Long&#x02010;term statin exposure increases HDL's anti&#x02010;inflammatory and antioxidant capacity.<xref rid="jah32730-bib-0023" ref-type="ref">23</xref>, <xref rid="jah32730-bib-0026" ref-type="ref">26</xref>, <xref rid="jah32730-bib-0038" ref-type="ref">38</xref> In our study, the strength&#x000a0;of the association between high HDL cholesterol concentration and decreased AKI was greatest among patients receiving long&#x02010;term statin therapy, was related to dose of long&#x02010;term preoperative statin, and was enhanced among patients randomized to receive perioperative atorvastatin. Because HDL concentration did not differ between long&#x02010;term statin&#x02010;using patients and statin&#x02010;na&#x000ef;ve patients in this study, this observation is independent of any effect long&#x02010;term statin exposure has on HDL concentration but may be related to effects of statin treatment on HDL functional capacity.</p><p>Three recent, high&#x02010;quality, randomized clinical trials, including this study's parent trial, have demonstrated that perioperative statin treatment does not reduce postoperative AKI and may, in fact, be harmful.<xref rid="jah32730-bib-0027" ref-type="ref">27</xref>, <xref rid="jah32730-bib-0039" ref-type="ref">39</xref>, <xref rid="jah32730-bib-0040" ref-type="ref">40</xref> The evidence suggests that statins should not be initiated in the perioperative period to reduce AKI. Conversely, the results of the current study suggest, in a prospective, randomized, placebo&#x02010;controlled manner, that one 80&#x02010;mg dose of atorvastatin the morning of surgery and one 40&#x02010;mg dose the day after surgery can potentiate the association between high preoperative HDL concentration and a reduced risk of postoperative AKI. These data serve as a proof of concept that an HDL effect on AKI can be rapidly pharmacologically modified during the perioperative period. Because perioperative statin treatment has non&#x02013;HDL&#x02010;mediated detrimental renal effects that outweigh any beneficial effects on HDL function, other pharmacologic agents with the potential for improving HDL function are needed.</p><p>This study has limitations. These results provide no evidence of causation because we could not randomize similar patients to high or low HDL cholesterol concentration before surgery. Another weakness is the differential perioperative atorvastatin dosing regimen for long&#x02010;term statin users and statin&#x02010;na&#x000ef;ve patients, which could introduce potential bias into our assessment of long&#x02010;term statin effect on the association between HDL concentration and postoperative AKI and imprecision into our analysis of the effects of atorvastatin. To minimize patient risk, the parent trial only withheld statin use from long&#x02010;term statin&#x02010;using patients (administered placebo) on days in which statins would be withheld in usual clinical care, specifically the day of surgery and postoperative day 1, because the evidence at trial design suggested that statin withdrawal at surgery could be harmful.<xref rid="jah32730-bib-0041" ref-type="ref">41</xref>, <xref rid="jah32730-bib-0042" ref-type="ref">42</xref>, <xref rid="jah32730-bib-0043" ref-type="ref">43</xref>, <xref rid="jah32730-bib-0044" ref-type="ref">44</xref> Fortunately, the effect of perioperative atorvastatin on the association between HDL cholesterol concentration and &#x00394;SCr can be accurately assessed, because patients were randomly assigned to perioperative placebo or atorvastatin treatment. The choice to study serum creatinine concentration change instead of AKI consensus criteria as the primary outcome could also be considered a weakness. However, retaining serum creatinine concentration change as a continuous variable preserves effect size and power to identify statistically significant differences between groups.<xref rid="jah32730-bib-0045" ref-type="ref">45</xref>, <xref rid="jah32730-bib-0046" ref-type="ref">46</xref> Furthermore, using a continuous outcome allowed us to use latent variable mixture modeling, which provides superior risk factor estimation in AKI modeling compared with traditional linear models.<xref rid="jah32730-bib-0028" ref-type="ref">28</xref> Nonetheless, we confirmed our primary findings by comparing HDL cholesterol concentrations among patients who developed moderate or severe AKIN&#x02010;staged AKI with those who developed no or mild AKI and observed a similar association between increased HDL concentrations and decreased AKI.</p><p>Our current results have identified an association between elevated preoperative HDL cholesterol concentration and decreased risk of AKI after cardiac surgery, and notably, this association can be pharmacologically potentiated directly before surgery. Future studies examining the associations between perioperative statin exposure, the antioxidant, anti&#x02010;inflammatory, and cholesterol efflux capacities of HDL from patients undergoing cardiac surgery, and postoperative AKI risk are needed to elucidate the biological mechanisms underlying these findings.</p></sec><sec id="jah32730-sec-0022"><title>Sources of Funding</title><p>This work was supported by US National Institutes of Health T32 GM108554 (L.E. Smith), P01 HL116263 (Linton), K23 GM102676 and R01 GM112871 (Billings), UL1 TR000445, and the Vanderbilt University Medical Center Department of Anesthesiology.</p></sec><sec id="jah32730-sec-0023"><title>Disclosures</title><p>None.</p></sec></body><back><ack id="jah32730-sec-0021"><title>Acknowledgments</title><p>We thank Patricia Hendricks, RN, for nursing support and Martha Tanner, BA, for editorial assistance.</p></ack><ref-list content-type="cited-references" id="jah32730-bibl-0001"><title>References</title><ref id="jah32730-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah32730-cit-0001">
<string-name>
<surname>Ryd&#x000e9;n</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ahnve</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bell</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hammar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ivert</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sartipy</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Holzmann</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Acute kidney injury after coronary artery bypass grafting and long&#x02010;term risk of myocardial infarction and death</article-title>. <source>Int J Cardiol</source>. <year>2014</year>;<volume>172</volume>:<fpage>190</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">24502882</pub-id></mixed-citation></ref><ref id="jah32730-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah32730-cit-0002">
<string-name>
<surname>Pickering</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>SC</given-names>
</string-name>. <article-title>Acute kidney injury and prognosis after cardiopulmonary bypass: a meta&#x02010;analysis of cohort studies</article-title>. <source>Am J Kidney Dis</source>. <year>2015</year>;<volume>65</volume>:<fpage>283</fpage>&#x02013;<lpage>293</lpage>.<pub-id pub-id-type="pmid">25445101</pub-id></mixed-citation></ref><ref id="jah32730-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah32730-cit-0003">
<string-name>
<surname>Hobson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ozrazgat&#x02010;Baslanti</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kuxhausen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thottakkara</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Efron</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Moldawer</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Segal</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Bihorac</surname>
<given-names>A</given-names>
</string-name>. <article-title>Cost and mortality associated with postoperative acute kidney injury</article-title>. <source>Ann Surg</source>. <year>2015</year>;<volume>261</volume>:<fpage>1207</fpage>&#x02013;<lpage>1214</lpage>.<pub-id pub-id-type="pmid">24887982</pub-id></mixed-citation></ref><ref id="jah32730-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah32730-cit-0004">
<string-name>
<surname>Hu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>X</given-names>
</string-name>. <article-title>Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta&#x02010;analysis</article-title>. <source>J Cardiothorac Vasc Anesth</source>. <year>2016</year>;<volume>30</volume>:<fpage>82</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">26482484</pub-id></mixed-citation></ref><ref id="jah32730-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah32730-cit-0005">
<string-name>
<surname>Uchino</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Bellomo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Doig</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Morimatsu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Morgera</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Schetz</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bouman</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Macedo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Gibney</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tolwani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ronco</surname>
<given-names>C</given-names>
</string-name>; <collab collab-type="authors">The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators</collab>
. <article-title>Acute renal failure in critically ill patients: a multinational, multicenter study</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>294</volume>:<fpage>813</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">16106006</pub-id></mixed-citation></ref><ref id="jah32730-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah32730-cit-0006">
<string-name>
<surname>Mehta</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kellum</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Shah</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Molitoris</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Ronco</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Warnock</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Levin</surname>
<given-names>A</given-names>
</string-name>; <collab collab-type="authors">The Acute Kidney Injury Network</collab>
. <article-title>Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury</article-title>. <source>Crit Care</source>. <year>2007</year>;<volume>11</volume>:<fpage>R31</fpage>.<pub-id pub-id-type="pmid">17331245</pub-id></mixed-citation></ref><ref id="jah32730-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah32730-cit-0007">
<string-name>
<surname>Kwon</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>S&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Ramesh</surname>
<given-names>G</given-names>
</string-name>. <article-title>Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia&#x02010;reperfusion</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2009</year>;<volume>296</volume>:<fpage>F25</fpage>&#x02013;<lpage>F33</lpage>.<pub-id pub-id-type="pmid">18971208</pub-id></mixed-citation></ref><ref id="jah32730-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah32730-cit-0008">
<string-name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Brodsky</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Noiri</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kajiya</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Goligorsky</surname>
<given-names>MS</given-names>
</string-name>. <article-title>Intravital videomicroscopy of peritubular capillaries in renal ischemia</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2002</year>;<volume>282</volume>:<fpage>F1150</fpage>&#x02013;<lpage>F1155</lpage>.<pub-id pub-id-type="pmid">11997332</pub-id></mixed-citation></ref><ref id="jah32730-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah32730-cit-0009">
<string-name>
<surname>Sutton</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Mang</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Campos</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Sandoval</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Yoder</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Molitoris</surname>
<given-names>BA</given-names>
</string-name>. <article-title>Injury of the renal microvascular endothelium alters barrier function after ischemia</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2003</year>;<volume>285</volume>:<fpage>F191</fpage>&#x02013;<lpage>F198</lpage>.<pub-id pub-id-type="pmid">12684225</pub-id></mixed-citation></ref><ref id="jah32730-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah32730-cit-0010">
<string-name>
<surname>Zhang</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Garg</surname>
<given-names>AX</given-names>
</string-name>, <string-name>
<surname>Coca</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Devereaux</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Eikelboom</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kavsak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>McArthur</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Thiessen&#x02010;Philbrook</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shortt</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Shlipak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Whitlock</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Parikh</surname>
<given-names>CR</given-names>
</string-name>; <collab collab-type="authors">The TRIBE&#x02010;AKI Consortium</collab>
. <article-title>Plasma IL&#x02010;6 and IL&#x02010;10 concentrations predict AKI and long&#x02010;term mortality in adults after cardiac surgery</article-title>. <source>J Am Soc Nephrol</source>. <year>2015</year>;<volume>26</volume>:<fpage>3123</fpage>&#x02013;<lpage>3132</lpage>.<pub-id pub-id-type="pmid">25855775</pub-id></mixed-citation></ref><ref id="jah32730-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah32730-cit-0011">
<string-name>
<surname>Billings</surname>
<given-names>FT</given-names>
</string-name>, <string-name>
<surname>Pretorius</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schildcrout</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Mercaldo</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Byrne</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Ikizler</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</string-name>. <article-title>Obesity and oxidative stress predict AKI after cardiac surgery</article-title>. <source>J Am Soc Nephrol</source>. <year>2012</year>;<volume>23</volume>:<fpage>1221</fpage>&#x02013;<lpage>1228</lpage>.<pub-id pub-id-type="pmid">22626819</pub-id></mixed-citation></ref><ref id="jah32730-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah32730-cit-0012">
<string-name>
<surname>Kwon</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>S&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Sutton</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Temm</surname>
<given-names>CJ</given-names>
</string-name>. <article-title>Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury</article-title>. <source>Am J Physiol Renal Physiol</source>. <year>2008</year>;<volume>295</volume>:<fpage>F351</fpage>&#x02013;<lpage>F359</lpage>.<pub-id pub-id-type="pmid">18562634</pub-id></mixed-citation></ref><ref id="jah32730-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah32730-cit-0013">
<string-name>
<surname>Murphy</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Woollard</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Hoang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mukhamedova</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Stirzaker</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>McCormick</surname>
<given-names>SPA</given-names>
</string-name>, <string-name>
<surname>Remaley</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Sviridov</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chin&#x02010;Dusting</surname>
<given-names>J</given-names>
</string-name>. <article-title>High&#x02010;density lipoprotein reduces the human monocyte inflammatory response</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2008</year>;<volume>28</volume>:<fpage>2071</fpage>&#x02013;<lpage>2077</lpage>.<pub-id pub-id-type="pmid">18617650</pub-id></mixed-citation></ref><ref id="jah32730-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah32730-cit-0014">
<string-name>
<surname>Yuhanna</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Hahner</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>Osborne&#x02010;Lawrence</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Marcel</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Mendelsohn</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Hobbs</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Shaul</surname>
<given-names>PW</given-names>
</string-name>. <article-title>High&#x02010;density lipoprotein binding to scavenger receptor&#x02010;BI activates endothelial nitric oxide synthase</article-title>. <source>Nat Med</source>. <year>2001</year>;<volume>7</volume>:<fpage>853</fpage>&#x02013;<lpage>857</lpage>.<pub-id pub-id-type="pmid">11433352</pub-id></mixed-citation></ref><ref id="jah32730-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jah32730-cit-0015">
<string-name>
<surname>Bisoendial</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Hovingh</surname>
<given-names>GK</given-names>
</string-name>, <string-name>
<surname>Levels</surname>
<given-names>JHM</given-names>
</string-name>, <string-name>
<surname>Lerch</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Andresen</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hayden</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Kastelein</surname>
<given-names>JJP</given-names>
</string-name>, <string-name>
<surname>Stroes</surname>
<given-names>ESG</given-names>
</string-name>. <article-title>Restoration of endothelial function by increasing high&#x02010;density lipoprotein in subjects with isolated low high&#x02010;density lipoprotein</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>107</volume>:<fpage>2944</fpage>&#x02013;<lpage>2948</lpage>.<pub-id pub-id-type="pmid">12771001</pub-id></mixed-citation></ref><ref id="jah32730-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah32730-cit-0016">
<string-name>
<surname>Tso</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Martinic</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>W&#x02010;H</given-names>
</string-name>, <string-name>
<surname>Rogers</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rye</surname>
<given-names>K&#x02010;A</given-names>
</string-name>, <string-name>
<surname>Barter</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>High&#x02010;density lipoproteins enhance progenitor&#x02010;mediated endothelium repair in mice</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2006</year>;<volume>26</volume>:<fpage>1144</fpage>&#x02013;<lpage>1149</lpage>.<pub-id pub-id-type="pmid">16528007</pub-id></mixed-citation></ref><ref id="jah32730-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah32730-cit-0017">
<string-name>
<surname>Wan Ahmad</surname>
<given-names>WNH</given-names>
</string-name>, <string-name>
<surname>Sakri</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Mokhsin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mohd Nasir</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Abdul&#x02010;Razak</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Md Yasin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mohd Ismail</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ismail</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Nawawi</surname>
<given-names>H</given-names>
</string-name>. <article-title>Low serum high density lipoprotein cholesterol concentration is an independent predictor for enhanced inflammation and endothelial activation</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>:<fpage>e0116867</fpage>.<pub-id pub-id-type="pmid">25614985</pub-id></mixed-citation></ref><ref id="jah32730-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah32730-cit-0018">
<string-name>
<surname>Navab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hama</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Cooke</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Anantharamaiah</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Chaddha</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Subbanagounder</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Faull</surname>
<given-names>KF</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Fogelman</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1</article-title>. <source>J Lipid Res</source>. <year>2000</year>;<volume>41</volume>:<fpage>1481</fpage>&#x02013;<lpage>1494</lpage>.<pub-id pub-id-type="pmid">10974056</pub-id></mixed-citation></ref><ref id="jah32730-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah32730-cit-0019">
<string-name>
<surname>Navab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Berliner</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Subbanagounder</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lusis</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Castellani</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shih</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Watson</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Van Lenten</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Vora</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Fogelman</surname>
<given-names>AM</given-names>
</string-name>. <article-title>HDL and the inflammatory response induced by LDL&#x02010;derived oxidized phospholipids</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2001</year>;<volume>21</volume>:<fpage>481</fpage>&#x02013;<lpage>488</lpage>.<pub-id pub-id-type="pmid">11304461</pub-id></mixed-citation></ref><ref id="jah32730-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah32730-cit-0020">
<string-name>
<surname>Navab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hama</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Anantharamaiah</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Hassan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hough</surname>
<given-names>GP</given-names>
</string-name>, <string-name>
<surname>Watson</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Sevanian</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fonarow</surname>
<given-names>GC</given-names>
</string-name>, <string-name>
<surname>Fogelman</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3</article-title>. <source>J Lipid Res</source>. <year>2000</year>;<volume>41</volume>:<fpage>1495</fpage>&#x02013;<lpage>1508</lpage>.<pub-id pub-id-type="pmid">10974057</pub-id></mixed-citation></ref><ref id="jah32730-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah32730-cit-0021">
<string-name>
<surname>Cirstea</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Walley</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Russell</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Brunham</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Genga</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>JH</given-names>
</string-name>. <article-title>Decreased high&#x02010;density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis</article-title>. <source>J Crit Care</source>. <year>2017</year>;<volume>38</volume>:<fpage>289</fpage>&#x02013;<lpage>294</lpage>.<pub-id pub-id-type="pmid">28013095</pub-id></mixed-citation></ref><ref id="jah32730-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah32730-cit-0022">
<string-name>
<surname>Chien</surname>
<given-names>Y&#x02010;F</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>C&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>C&#x02010;L</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>K&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>C&#x02010;J</given-names>
</string-name>. <article-title>Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community&#x02010;acquired pneumonia that required intensive care unit admission</article-title>. <source>J Crit Care</source>. <year>2015</year>;<volume>30</volume>:<fpage>506</fpage>&#x02013;<lpage>510</lpage>.<pub-id pub-id-type="pmid">25702844</pub-id></mixed-citation></ref><ref id="jah32730-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah32730-cit-0023">
<string-name>
<surname>Ferretti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bacchetti</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sahebkar</surname>
<given-names>A</given-names>
</string-name>. <article-title>Effect of statin therapy on paraoxonase&#x02010;1 status: a systematic review and meta&#x02010;analysis of 25 clinical trials</article-title>. <source>Prog Lipid Res</source>. <year>2015</year>;<volume>60</volume>:<fpage>50</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">26416579</pub-id></mixed-citation></ref><ref id="jah32730-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah32730-cit-0024">
<string-name>
<surname>Barter</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Brandrup&#x02010;Wognsen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Nicholls</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>Effect of statins on HDL&#x02010;C: a complex process unrelated to changes in LDL&#x02010;C: analysis of the VOYAGER Database</article-title>. <source>J Lipid Res</source>. <year>2010</year>;<volume>51</volume>:<fpage>1546</fpage>&#x02013;<lpage>1553</lpage>.<pub-id pub-id-type="pmid">19965573</pub-id></mixed-citation></ref><ref id="jah32730-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah32730-cit-0025">
<string-name>
<surname>Stancu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sima</surname>
<given-names>A</given-names>
</string-name>. <article-title>Statins: mechanism of action and effects</article-title>. <source>J Cell Mol Med</source>. <year>2001</year>;<volume>5</volume>:<fpage>378</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">12067471</pub-id></mixed-citation></ref><ref id="jah32730-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah32730-cit-0026">
<string-name>
<surname>Ansell</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Navab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hama</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kamranpour</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fonarow</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hough</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rahmani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mottahedeh</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dave</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Fogelman</surname>
<given-names>AM</given-names>
</string-name>. <article-title>Inflammatory/antiinflammatory properties of high&#x02010;density lipoprotein distinguish patients from control subjects better than high&#x02010;density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>108</volume>:<fpage>2751</fpage>&#x02013;<lpage>2756</lpage>.<pub-id pub-id-type="pmid">14638544</pub-id></mixed-citation></ref><ref id="jah32730-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah32730-cit-0027">
<string-name>
<surname>Billings</surname>
<given-names>FT</given-names>
</string-name>, <string-name>
<surname>Hendricks</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Schildcrout</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Petracek</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Byrne</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</string-name>. <article-title>High&#x02010;dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>315</volume>:<fpage>877</fpage>&#x02013;<lpage>888</lpage>.<pub-id pub-id-type="pmid">26906014</pub-id></mixed-citation></ref><ref id="jah32730-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah32730-cit-0028">
<string-name>
<surname>Smith</surname>
<given-names>LE</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Blume</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Siew</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Billings</surname>
<given-names>FT</given-names>
</string-name>. <article-title>Latent variable modeling improves AKI risk factor identification and AKI prediction compared to traditional methods</article-title>. <source>BMC Nephrol</source>. <year>2017</year>;<volume>18</volume>:<fpage>55</fpage>.<pub-id pub-id-type="pmid">28178929</pub-id></mixed-citation></ref><ref id="jah32730-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah32730-cit-0029">
<string-name>
<surname>Levey</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>YL</given-names>
</string-name>, <string-name>
<surname>Castro</surname>
<given-names>AF</given-names>
<suffix>III</suffix>
</string-name>, <string-name>
<surname>Feldman</surname>
<given-names>HI</given-names>
</string-name>, <string-name>
<surname>Kusek</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Eggers</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Van Lente</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Greene</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Coresh</surname>
<given-names>J</given-names>
</string-name>; <collab collab-type="authors">The Chronic Kidney Disease Epidemiology Collaboration (CKD&#x02010;EPI)</collab>
. <article-title>A new equation&#x000a0;to estimate glomerular filtration rate</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>150</volume>:<fpage>604</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">19414839</pub-id></mixed-citation></ref><ref id="jah32730-bib-0030"><label>30</label><mixed-citation publication-type="book" id="jah32730-cit-0030">
<article-title>FDA Drug Safety Communication: new restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury: relative LDL&#x02010;lowering efficacy of statin and statin&#x02010;based therapies</article-title>. <publisher-name>US Food and Drug Administration</publisher-name> Website. Last updated March 8, <year>2016</year>
<ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/Drugs/DrugSafety/ucm256581.htm">https://www.fda.gov/Drugs/DrugSafety/ucm256581.htm</ext-link>. Published June 8, 2011. Accessed June 7, 2017.</mixed-citation></ref><ref id="jah32730-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah32730-cit-0031">
<string-name>
<surname>Odden</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Tager</surname>
<given-names>IB</given-names>
</string-name>, <string-name>
<surname>Gansevoort</surname>
<given-names>RT</given-names>
</string-name>, <string-name>
<surname>Bakker</surname>
<given-names>SJL</given-names>
</string-name>, <string-name>
<surname>Fried</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Newman</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Katz</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Satterfield</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>TB</given-names>
</string-name>, <string-name>
<surname>Sarnak</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Siscovick</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shlipak</surname>
<given-names>MG</given-names>
</string-name>. <article-title>Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study</article-title>. <source>Ann Epidemiol</source>. <year>2013</year>;<volume>23</volume>:<fpage>106</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">23313266</pub-id></mixed-citation></ref><ref id="jah32730-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jah32730-cit-0032">
<string-name>
<surname>Shroff</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Speer</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Colin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Charakida</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zewinger</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Staels</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Chinetti&#x02010;Gbaguidi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hettrich</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Rohrer</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>O'Neill</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>McLoughlin</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shanahan</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Landmesser</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Fliser</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Deanfield</surname>
<given-names>JE</given-names>
</string-name>. <article-title>HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype</article-title>. <source>J Am Soc Nephrol</source>. <year>2014</year>;<volume>25</volume>:<fpage>2658</fpage>&#x02013;<lpage>2668</lpage>.<pub-id pub-id-type="pmid">24854267</pub-id></mixed-citation></ref><ref id="jah32730-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jah32730-cit-0033">
<string-name>
<surname>Kalantar&#x02010;Zadeh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kopple</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Kamranpour</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Fogelman</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Navab</surname>
<given-names>M</given-names>
</string-name>. <article-title>HDL&#x02010;inflammatory index correlates with poor outcome in hemodialysis patients</article-title>. <source>Kidney Int</source>. <year>2007</year>;<volume>72</volume>:<fpage>1149</fpage>&#x02013;<lpage>1156</lpage>.<pub-id pub-id-type="pmid">17728705</pub-id></mixed-citation></ref><ref id="jah32730-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jah32730-cit-0034">
<string-name>
<surname>Kennedy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Tang</surname>
<given-names>WHW</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mann</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pepoy</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hazen</surname>
<given-names>SL</given-names>
</string-name>. <article-title>Diminished antioxidant activity of high&#x02010;density lipoprotein&#x02013;associated proteins in chronic kidney disease</article-title>. <source>J Am Heart Assoc</source>. <year>2013</year>;<volume>2</volume>:<fpage>e000104</fpage> DOI: <ext-link ext-link-type="doi" xlink:href="10.1161/JAHA.112.000104">10.1161/JAHA.112.000104</ext-link>.<pub-id pub-id-type="pmid">23557751</pub-id></mixed-citation></ref><ref id="jah32730-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jah32730-cit-0035">
<string-name>
<surname>Yamamoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yancey</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Ikizler</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Jerome</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Kaseda</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bian</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shintani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fogo</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Linton</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Fazio</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kon</surname>
<given-names>V</given-names>
</string-name>. <article-title>Dysfunctional high&#x02010;density lipoprotein in patients on chronic hemodialysis</article-title>. <source>J Am Coll Cardiol</source>. <year>2012</year>;<volume>60</volume>:<fpage>2372</fpage>&#x02013;<lpage>2379</lpage>.<pub-id pub-id-type="pmid">23141484</pub-id></mixed-citation></ref><ref id="jah32730-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jah32730-cit-0036">
<string-name>
<surname>Wolfs</surname>
<given-names>TGAM</given-names>
</string-name>, <string-name>
<surname>Buurman</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>van Schadewijk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Daemen</surname>
<given-names>MARC</given-names>
</string-name>, <string-name>
<surname>Hiemstra</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>van &#x02018;t Veer</surname>
<given-names>C</given-names>
</string-name>. <article-title>In vivo expression of Toll&#x02010;like receptor 2 and 4 by renal epithelial cells: IFN&#x02010;gamma and TNF&#x02010;alpha mediated up&#x02010;regulation during inflammation</article-title>. <source>J Immunol</source>. <year>2002</year>;<volume>168</volume>:<fpage>1286</fpage>&#x02013;<lpage>1293</lpage>.<pub-id pub-id-type="pmid">11801667</pub-id></mixed-citation></ref><ref id="jah32730-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jah32730-cit-0037">
<string-name>
<surname>Wu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wyburn</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bertolino</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Eris</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Alexander</surname>
<given-names>SI</given-names>
</string-name>, <string-name>
<surname>Sharland</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Chadban</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>TLR4 activation mediates kidney ischemia/reperfusion injury</article-title>. <source>J Clin Invest</source>. <year>2007</year>;<volume>117</volume>:<fpage>2847</fpage>&#x02013;<lpage>2859</lpage>.<pub-id pub-id-type="pmid">17853945</pub-id></mixed-citation></ref><ref id="jah32730-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jah32730-cit-0038">
<string-name>
<surname>Gordon</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>McKenzie</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kemeh</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sampson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Perl</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Fessler</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Remaley</surname>
<given-names>AT</given-names>
</string-name>. <article-title>Rosuvastatin alters the proteome of high density lipoproteins: generation of alpha&#x02010;1&#x02010;antitrypsin enriched particles with anti&#x02010;inflammatory properties</article-title>. <source>Mol Cell Proteomics</source>. <year>2015</year>;<volume>14</volume>:<fpage>3247</fpage>&#x02013;<lpage>3257</lpage>.<pub-id pub-id-type="pmid">26483418</pub-id></mixed-citation></ref><ref id="jah32730-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jah32730-cit-0039">
<string-name>
<surname>Park</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Shim</surname>
<given-names>J&#x02010;K</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>J&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Soh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kwak</surname>
<given-names>Y&#x02010;L</given-names>
</string-name>. <article-title>Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo&#x02010;controlled trial</article-title>. <source>Intensive Care Med</source>. <year>2016</year>;<volume>42</volume>:<fpage>1398</fpage>&#x02013;<lpage>1407</lpage>.<pub-id pub-id-type="pmid">27120082</pub-id></mixed-citation></ref><ref id="jah32730-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jah32730-cit-0040">
<string-name>
<surname>Zheng</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Jayaram</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Emberson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Guarguagli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Casadei</surname>
<given-names>B</given-names>
</string-name>. <article-title>Perioperative rosuvastatin in cardiac surgery</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>374</volume>:<fpage>1744</fpage>&#x02013;<lpage>1753</lpage>.<pub-id pub-id-type="pmid">27144849</pub-id></mixed-citation></ref><ref id="jah32730-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jah32730-cit-0041">
<string-name>
<surname>Heeschen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hamm</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Laufs</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Snapinn</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>B&#x000f6;hm</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>HD</given-names>
</string-name>; <collab collab-type="authors">The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators</collab>
. <article-title>Withdrawal of statins increases event rates in patients with acute coronary syndromes</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>105</volume>:<fpage>1446</fpage>&#x02013;<lpage>1452</lpage>.<pub-id pub-id-type="pmid">11914253</pub-id></mixed-citation></ref><ref id="jah32730-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jah32730-cit-0042">
<string-name>
<surname>Di Sciascio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Patti</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pasceri</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gaspardone</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Colonna</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Montinaro</surname>
<given-names>A</given-names>
</string-name>. <article-title>Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA&#x02010;RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>54</volume>:<fpage>558</fpage>&#x02013;<lpage>565</lpage>.<pub-id pub-id-type="pmid">19643320</pub-id></mixed-citation></ref><ref id="jah32730-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jah32730-cit-0043">
<string-name>
<surname>Billings</surname>
<given-names>FT</given-names>
</string-name>, <string-name>
<surname>Pretorius</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Siew</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>NJ</given-names>
</string-name>. <article-title>Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery</article-title>. <source>J Cardiothorac Vasc Anesth</source>. <year>2010</year>;<volume>24</volume>:<fpage>913</fpage>&#x02013;<lpage>920</lpage>.<pub-id pub-id-type="pmid">20599398</pub-id></mixed-citation></ref><ref id="jah32730-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jah32730-cit-0044">
<string-name>
<surname>Kor</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Iscimen</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Whalen</surname>
<given-names>FX</given-names>
</string-name>, <string-name>
<surname>Roy</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Keegan</surname>
<given-names>MT</given-names>
</string-name>. <article-title>Perioperative statin therapy and renal outcomes after major vascular surgery: a propensity&#x02010;based analysis</article-title>. <source>J Cardiothorac Vasc Anesth</source>. <year>2008</year>;<volume>22</volume>:<fpage>210</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">18375322</pub-id></mixed-citation></ref><ref id="jah32730-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jah32730-cit-0045">
<string-name>
<surname>Fitzsimons</surname>
<given-names>GJ</given-names>
</string-name>. <article-title>Death to dichotomizing</article-title>. <source>J Consum Res</source>. <year>2008</year>;<volume>35</volume>:<fpage>5</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="jah32730-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jah32730-cit-0046">
<string-name>
<surname>Dawson</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Weiss</surname>
<given-names>R</given-names>
</string-name>. <article-title>Dichotomizing continuous variables in statistical analysis: a practice to avoid</article-title>. <source>Med Decis Making</source>. <year>2012</year>;<volume>32</volume>:<fpage>225</fpage>&#x02013;<lpage>226</lpage>.<pub-id pub-id-type="pmid">22457338</pub-id></mixed-citation></ref></ref-list></back></article>